News

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...
Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
The U.S. Food and Drug Administration said Tuesday it will expand its use of unannounced inspections at foreign manufacturing ...
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...
High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...
The U.S. Food and Drug Administration said New England Village Foods has recalled its 19th Hole Snack Mix because the product ...
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
The Department of Justice on Monday said a lawsuit against the Food and Drug Administration seeking to sharply restrict the ...
OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency's use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI ...
If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...